Publication | Closed Access

Oral VV116 versus placebo in patients with mild-to-moderate COVID-19 in China: a multicentre, double-blind, phase 3, randomised controlled study

Mild-to-moderate Covid-19Treatment And PreventionCovid-19 PandemicAntiviral TherapyCovid-19 EpidemiologyPublic HealthMedicineEpidemiologyPhase 3Covid-19